These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 8892973

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Transforming growth factor-beta 1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor.
    Falcone DJ, McCaffrey TA, Haimovitz-Friedman A, Garcia M.
    J Cell Physiol; 1993 Jun; 155(3):595-605. PubMed ID: 7684044
    [Abstract] [Full Text] [Related]

  • 3. Transcriptional and posttranscriptional regulation of urokinase-type plasminogen activator expression in endothelial cells by basic fibroblast growth factor.
    Gualandris A, Presta M.
    J Cell Physiol; 1995 Mar; 162(3):400-9. PubMed ID: 7860647
    [Abstract] [Full Text] [Related]

  • 4. Regulation of urokinase plasminogen activator (uPA) activity by E-cadherin and hormones in mammary epithelial cells.
    Sasaki CY, Lin H, Passaniti A.
    J Cell Physiol; 1999 Oct; 181(1):1-13. PubMed ID: 10457348
    [Abstract] [Full Text] [Related]

  • 5. Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system.
    Fibbi G, D'Alessio S, Pucci M, Cerletti M, Del Rosso M.
    Biol Chem; 2002 Jan; 383(1):127-36. PubMed ID: 11928807
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator.
    Takano S, Gately S, Neville ME, Herblin WF, Gross JL, Engelhard H, Perricone M, Eidsvoog K, Brem S.
    Cancer Res; 1994 May 15; 54(10):2654-60. PubMed ID: 7513254
    [Abstract] [Full Text] [Related]

  • 8. Autocrine and paracrine regulation of tissue inhibitor of metalloproteinases, transin, and urokinase gene expression in metastatic and nonmetastatic mammary carcinoma cells.
    Korczak B, Kerbel RS, Dennis JW.
    Cell Growth Differ; 1991 Jul 15; 2(7):335-41. PubMed ID: 1782152
    [Abstract] [Full Text] [Related]

  • 9. Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel-Palade bodies in bovine microvascular endothelial cells.
    Pepper MS, Rosnoblet C, Di Sanza C, Kruithof EK.
    Thromb Haemost; 2001 Aug 15; 86(2):702-9. PubMed ID: 11522025
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity.
    Odekon LE, Sato Y, Rifkin DB.
    J Cell Physiol; 1992 Feb 15; 150(2):258-63. PubMed ID: 1734031
    [Abstract] [Full Text] [Related]

  • 12. The effect of transforming growth factor beta on the plasminogen activator activity of normal human osteoblast-like cells and a human osteosarcoma cell line MG-63.
    Fawthrop FW, Oyajobi BO, Bunning RA, Russell RG.
    J Bone Miner Res; 1992 Dec 15; 7(12):1363-71. PubMed ID: 1481722
    [Abstract] [Full Text] [Related]

  • 13. Keratinocyte growth factor enhances urokinase-type plasminogen activator activity in HPV16 DNA-immortalized human uterine exocervical epithelial cells.
    Zheng J, Siren V, Vaheri A.
    Eur J Cell Biol; 1996 Feb 15; 69(2):128-34. PubMed ID: 8907612
    [Abstract] [Full Text] [Related]

  • 14. Ets-1 transcription factor-mediated urokinase-type plasminogen activator expression and invasion in glioma cells stimulated by serum and basic fibroblast growth factors.
    Kitange G, Shibata S, Tokunaga Y, Yagi N, Yasunaga A, Kishikawa M, Naito S.
    Lab Invest; 1999 Apr 15; 79(4):407-16. PubMed ID: 10211993
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Plasminogen activator system: implications for mammary cell growth and involution.
    Politis I.
    J Dairy Sci; 1996 Jun 15; 79(6):1097-107. PubMed ID: 8827475
    [Abstract] [Full Text] [Related]

  • 17. Urokinase expression and binding activity associated with the transforming growth factor beta1-induced migratory and invasive phenotype of mouse epidermal keratinocytes.
    Santibáñez JF, Frontelo P, Iglesias M, Martínez J, Quintanilla M.
    J Cell Biochem; 1999 Jul 01; 74(1):61-73. PubMed ID: 10381262
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis.
    Blei F, Wilson EL, Mignatti P, Rifkin DB.
    J Cell Physiol; 1993 Jun 01; 155(3):568-78. PubMed ID: 7684043
    [Abstract] [Full Text] [Related]

  • 19. Appearance of basic fibroblast growth factor receptors upon differentiation of rat mammary epithelial to myoepithelial-like cells in culture.
    Fernig DG, Smith JA, Rudland PS.
    J Cell Physiol; 1990 Jan 01; 142(1):108-16. PubMed ID: 2153686
    [Abstract] [Full Text] [Related]

  • 20. Intestinal transformation results in transforming growth factor-beta-dependent alteration in tumor cell-cell matrix interactions.
    Berger DH, O'Mahony CA, Sheng H, Shao J, Albo D, DuBois RN, Beauchamp RD.
    Surgery; 2003 May 01; 133(5):568-79. PubMed ID: 12773985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.